scholarly journals Adoptive Transfer of Autologous Invariant NKT Cells as Immunotherapy for Advanced Hepatocellular Carcinoma: A Phase I Clinical Trial

2021 ◽  
Author(s):  
Yao Gao ◽  
Jia Guo ◽  
Xuli Bao ◽  
Fang Xiong ◽  
Yanpin Ma ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Clinical Trial ◽  
Phase I ◽  
Adoptive Transfer ◽  
Nkt Cells ◽  
Phase I Clinical Trial ◽  
Advanced Hepatocellular Carcinoma ◽  
Invariant Nkt Cells

scholarly journals Adoptive Transfer of Invariant NKT Cells as Immunotherapy for Advanced Melanoma: A Phase I Clinical Trial

2017 ◽  
Vol 23 (14) ◽  
pp. 3510-3519 ◽  
Author(s):  
Mark A. Exley ◽  
Phillip Friedlander ◽  
Nadia Alatrakchi ◽  
Lianne Vriend ◽  
Simon Yue ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase I ◽  
Adoptive Transfer ◽  
Nkt Cells ◽  
Advanced Melanoma ◽  
Phase I Clinical Trial ◽  
Invariant Nkt Cells

A phase I clinical trial of S-1 in combination with sorafenib for patients with advanced hepatocellular carcinoma.

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. e14655-e14655
Author(s):  
J. Yi ◽  
H. Ahn ◽  
S. Lee ◽  
J. Uhm ◽  
J. Lee ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Clinical Trial ◽  
Phase I ◽  
Phase I Clinical Trial ◽  
Advanced Hepatocellular Carcinoma

Phase I clinical trial of continuous infusion of tyroserleutide in patients with advanced hepatocellular carcinoma

2011 ◽  
Vol 29 (3) ◽  
pp. 1850-1858 ◽  
Author(s):  
Zhen-Yu Xiao ◽  
Jin-Bin Jia ◽  
Lin Chen ◽  
Wei Zou ◽  
Xiao-Ping Chen
Keyword(s):  
Hepatocellular Carcinoma ◽  
Clinical Trial ◽  
Phase I ◽  
Continuous Infusion ◽  
Phase I Clinical Trial ◽  
Advanced Hepatocellular Carcinoma

scholarly journals A phase I clinical trial of thymidine kinase-based gene therapy in advanced hepatocellular carcinoma

2010 ◽  
Vol 17 (12) ◽  
pp. 837-843 ◽  
Author(s):  
B Sangro ◽  
G Mazzolini ◽  
M Ruiz ◽  
J Ruiz ◽  
J Quiroga ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Clinical Trial ◽  
Gene Therapy ◽  
Phase I ◽  
Thymidine Kinase ◽  
Phase I Clinical Trial ◽  
Advanced Hepatocellular Carcinoma

Phase I Clinical Trial of Targeted Therapy Using 131I-Hepama-1 mAb in Patients with Hepatocellular Carcinoma

2004 ◽  
Vol 19 (5) ◽  
pp. 589-600
Author(s):  
Shaoliang Chen ◽  
Beilei Li ◽  
Hong Xie ◽  
Li Xu ◽  
Guangjun Niu ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Clinical Trial ◽  
Targeted Therapy ◽  
Phase I ◽  
Phase I Clinical Trial

Phase I Clinical Trial of Targeted Therapy Using 131I-Hepama-1 mAb in Patients with Hepatocellular Carcinoma

2004 ◽  
Vol 19 (5) ◽  
pp. 589-600 ◽  
Author(s):  
Shaoliang Chen ◽  
Beilei Li ◽  
Hong Xie ◽  
Li Xu ◽  
Guangjun Niu ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Clinical Trial ◽  
Targeted Therapy ◽  
Phase I ◽  
Phase I Clinical Trial

Preliminary Results of Hepatocellular Carcinoma Patients Treated by Talaporfin Sodium and Interstitial Light Emitting Diodes – A Phase I Clinical Trial

2006 ◽  
Vol 101 ◽  
pp. S190
Author(s):  
Wei-Chen Lee ◽  
Sheng-Nan Lu ◽  
Yi-Hong Chou ◽  
Jeng-Hwei Tseng ◽  
Jing-Houng Wang ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Clinical Trial ◽  
Phase I ◽  
Light Emitting Diodes ◽  
Phase I Clinical Trial ◽  
Light Emitting ◽  
Talaporfin Sodium ◽  
Preliminary Results

scholarly journals A phase I clinical trial utilizing autologous tumor-infiltrating lymphocytes in patients with primary hepatocellular carcinoma

Oncotarget ◽  
2015 ◽  
Vol 6 (38) ◽  
pp. 41339-41349 ◽  
Author(s):  
Shan-Shan Jiang ◽  
Yan Tang ◽  
Yao-Jun Zhang ◽  
De-Sheng Weng ◽  
Zhong-Guo Zhou ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Clinical Trial ◽  
Phase I ◽  
Tumor Infiltrating Lymphocytes ◽  
Phase I Clinical Trial ◽  
Primary Hepatocellular Carcinoma ◽  
Autologous Tumor ◽  
Infiltrating Lymphocytes
Sign in / Sign up

Export Citation Format

Share Document